2006
DOI: 10.1258/000456306778904731
|View full text |Cite
|
Sign up to set email alerts
|

Current perspectives in protein array technology

Abstract: AddressesThis article reviews post-2000 trends in the development of two-dimensional protein microarrays and nanoarrays. Progress in array manufacture, assay design and applications are considered, with an emphasis on issues surrounding the implementation of arrays in clinical diagnostics. These include the effect of factors in the pre-analytical phase (quality of the reagents, sample integrity, etc.), and those in the analytical phase that contribute to inaccuracy and imprecision of an array-based assay. Impo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
47
0
1

Year Published

2007
2007
2015
2015

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 62 publications
(48 citation statements)
references
References 81 publications
0
47
0
1
Order By: Relevance
“…cytokines and adhesion molecules) in a single patient sample and provides valuable information relating to each tested ana-lyte and possible associations between analytes in each sample 15,16 . The core technology is the biochip, a solidstate device containing an array of discrete test regions of immobilised antibodies specific to different cytokines and adhesion molecules.…”
Section: Multi-analytical Evaluation Using Biochip Array Technologymentioning
confidence: 99%
“…cytokines and adhesion molecules) in a single patient sample and provides valuable information relating to each tested ana-lyte and possible associations between analytes in each sample 15,16 . The core technology is the biochip, a solidstate device containing an array of discrete test regions of immobilised antibodies specific to different cytokines and adhesion molecules.…”
Section: Multi-analytical Evaluation Using Biochip Array Technologymentioning
confidence: 99%
“…In these assays, the need to separate unbound probe molecules from bound ones is avoided and this provides significant advantages such as convenience, speed, and accuracy of DNA analysis. [2][3][4][5] Most of the current specific detection systems rely on the use of labeled oligonucleotide-based probe molecules that bind to their DNA target in a sequence-specific manner. Most commonly, bound probes are distinguished from unbound probes by hybridization-induced spatial convergence or separation of two markers that interact through fluorescence resonance energy transfer (FRET).…”
Section: Introductionmentioning
confidence: 99%
“…[6] These attractive characteristics enabled DNA to be detected for the first time at a sensitivity comparable to that of radioactive probes, but without the danger inherent in radioactivity. [7] Although some sequence specificity that might lead to inhomogeneous staining has been demonstrated for both TOTO and, to a lesser extent, YOYO, [8][9][10] these cyanines and some derivatives have been used as general DNA stains in numerous DNA detection and quantitation assays, [11] such as the polymerase chain reaction, [12,13] DNA staining and fragment sizing, [14][15][16][17][18] DNA damage detection, [19,20] flow cytometry, [16,21,22] evaluation of biological activity, [23,24] DNA imaging [25][26][27][28] and DNA photocleavage. [29][30][31] YO and TO have also been covalently linked to oligonucleotides and inserted into peptide nucleic acids constructs, which become fluorescent upon hybridisation of the light-up probe to a specific complementary strand.…”
mentioning
confidence: 99%